Product Information
METOPROLOL TARTRATE 75 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.1541 per EA under NDC 72888002301. Its NADAC has been published 229 times since May 18, 2022.
FDA first approved this application on Oct 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888002301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200981FDA Approved
10/28/2014
TE Code
AB
On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL TARTRATE 75 MG TAB has been published 229 times since May 18, 2022, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1541 per EA |
|---|---|
| All-time high | $0.1712 (Aug 10, 2022) |
| All-time low | $0.1090 (Jul 17, 2024) |
| 52-week high | $0.1541 |
| 52-week low | $0.1332 |
| Median price | $0.1503 |
| Average price | $0.1490 |
| Largest weekly change | -27.9% (Apr 17, 2024) |
| Weeks tracked | 229 |
| Tracking since | May 18, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METOPROLOL TARTRATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METOPROLOL TARTRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL TARTRATE 75 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 75 MG TAB, manufactured by Advagen Pharma Ltd., is $0.1541 per EA (NDC 72888002301), effective Sep 30, 2026.
How has the price of METOPROLOL TARTRATE 75 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL TARTRATE 75 MG TAB has declined 2.3%. It has been tracked across 229 weekly CMS publications since May 18, 2022.
What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 75 MG TAB?
Since May 18, 2022, the NADAC for METOPROLOL TARTRATE 75 MG TAB has ranged from a low of $0.1090 (Jul 17, 2024) to a high of $0.1712 (Aug 10, 2022), with a median of $0.1503 per EA.
Are there cheaper alternatives to METOPROLOL TARTRATE 75 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of METOPROLOL TARTRATE 75 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METOPROLOL TARTRATE 75 MG TAB?
METOPROLOL TARTRATE 75 MG TAB (NDC 72888002301) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.